coagulation factor IX (recombinant human), albumin fusion protein 1 UNT Injection
- RxCUI
- 1743994
- RxNorm name
- coagulation factor IX (recombinant human), albumin fusion protein 1 UNT Injection
- Display name
- coagulation factor IX (recombinant human), albumin fusion protein 1 UNT Injection
- Full name
- coagulation factor IX (recombinant human), albumin fusion protein 1 UNT Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125582 | Idelvion | Coagulation Factor IX (Recombinant), Albumin Fusion Protein | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f74301bf-95e2-44ab-a8b6-98aa07b04683 | albutrepenonacog alfa 1 UNT Injection [PSN] · albutrepenonacog alfa 1 UNT Injection [SCD] · coagulation factor IX (recombinant human), albumin fusion protein 1 UNT Injection [SY] | 3 | 12 | These highlights do not include all the information needed to use IDELVION ® safely and effectively. See full prescribing information for IDELVION. IDELVION [Coagulation Factor IX (Recombinant), Albumin Fusion Protein] Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2016 | 20230630 |